Human COVID-19 Immunoglobulin (COVID-HIG) Therapy for COVID-19 Patients
Clinical trial NCT05173441 · UNKNOWN
Trial details
- NCT number
- NCT05173441
- Sponsor
- Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-30
- Primary completion
- 2023-06-20
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.